Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
about
Is There Still Room for Cancer Vaccines at the Era of Checkpoint InhibitorsThe anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin.Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4(+) T cell responses protecting from airway challenge with recombinant vaccinia-gag virus.CTI special feature on innate immune responses and vaccine design.Liposomal adjuvant development for leishmaniasis vaccines.Decorating and loading ghosts with allergens for allergen immunotherapy.IL-6 Production by TLR-Activated APC Broadly Enhances Aged Cognate CD4 Helper and B Cell Antibody Responses In Vivo.Modulating the immune system through nanotechnology.Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment.Human Milk Oligosaccharide 2'-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model.Targeting Mycobacterium tuberculosis Antigens to Dendritic Cells via the DC-Specific-ICAM3-Grabbing-Nonintegrin Receptor Induces Strong T-Helper 1 Immune Responses.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting.Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils.Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery
P2860
Q28072532-F91F6FC8-6954-4E73-A02F-F449B7B92B25Q38369004-8B942E98-1B63-49D8-993F-3A1EDB1674BFQ39450802-EC5C5F83-6429-40A8-A038-8656A6A91233Q40214060-BB7E5B47-F367-4DB8-A85D-31D608844353Q42399018-D149362D-21B3-4014-9D52-7147045BB619Q47153161-F8326EB7-4156-4454-9EC0-FA04481CFBA7Q47937079-DACC2AEB-66BE-41D8-AAED-440E4E732853Q48176976-8806109B-7862-423E-B27E-56EEFE8C55A0Q48630939-69A03013-3B81-44E2-BB40-2EBD1E6F24E2Q49835172-19D31995-F087-4580-A9C8-A097B3AB1457Q52338699-F77AAA66-FE54-4657-8045-6DA9AC37583DQ52584422-5A08ECD4-EC97-4AB4-A40B-FFB881E21192Q52746279-CD59B0EE-90E0-4AC6-A340-6E219F1108B1Q54942043-7B410947-2C1B-4D05-BF07-F7ABADFA1B14Q55081546-4146AEAA-CC0D-4DBB-AE29-7DC1AEC810A4Q55258910-2F7CE0E0-4FBC-49E9-8677-CACA1D7AFC53Q58803479-45A92252-E464-4B70-BCBF-FF1F7B2ADA11
P2860
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@ast
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@en
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@nl
type
label
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@ast
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@en
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@nl
prefLabel
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@ast
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@en
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@nl
P2093
P2860
P3181
P356
P1476
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
@en
P2093
Angus Pr Johnston
Claire Dumont
Justine D Mintern
P2860
P3181
P356
10.1038/CTI.2016.6
P407
P577
2016-03-01T00:00:00Z